Decoy Therapeutics is trading 5.5% down at $5.66 today, extending a recent pullback amid ongoing volatility in speculative micro-cap biotech names and a broader risk-off backdrop in U.S. equities.
- The decline follows a period of strength in late June that was driven by positive funding and pipeline updates.
- No new company-specific catalysts or fundamental shifts have been reported today to account for the price action.